L

Lexeo Therapeutics

Gene therapy for cardiac, neurological diseases

Associate Director - Marketing

Product MarketingConfirmed live in the last 24 hours
Full-timeNew York, NY, USA$170k - $230k /yr

About the Job

Requirements

  • An MBA or other advanced degree is required.
  • At least 7 years of biopharmaceutical industry experience, including direct marketing experience on a launch brand and/or in rare disease.
  • Demonstrated experience developing brand strategy, positioning, and healthcare professional and/or patient campaigns, including agency management and medical/legal/regulatory review.
  • Hands-on experience designing and managing primary market research and translating insights into strategy.
  • Strong analytical skills, including comfort working with claims and other secondary data, forecasts, and market sizing.
  • Project management skills and the ability to lead cross-functional teams without direct authority while managing multiple workstreams.
  • Written and verbal communication skills, including the ability to synthesize complex information into concise, executive-ready narratives for senior leadership and the Board.
  • Working knowledge of U.S. compliance requirements governing pre-approval and promotional activities.
  • Ability to travel as needed for medical congresses, advisory boards, vendor meetings, and treatment center meetings.

Responsibilities

  • Partner with the Senior Director, Marketing to enhance and execute the LX2006 U.S. launch strategy and brand plan, including strategic imperatives, positioning, target patient definition, and the pre-launch market development plan.
  • Translate the LX2006 strategy into an integrated launch roadmap and prepare materials for Launch Readiness Reviews, senior leadership and Board discussions, and investor calls.
  • Define launch key performance indicators and the analytics and customer relationship management capabilities needed to track launch performance.
  • Serve as a core member of the cross-functional U.S. and ex-U.S. Launch Readiness Teams; drive launch timelines, deliverables, interdependencies, risks, and decisions across Commercial, Medical Affairs, Patient Affairs, Market Access/Health Economics and Outcomes Research, Regulatory, Clinical, Legal, and Chemistry, Manufacturing, and Controls.
  • Lead the healthcare professional, patient/caregiver, and payer research program for LX2006, including awareness, trial and usage tracking, demand studies, message and concept testing, and advisory boards; translate findings into recommendations that shape positioning, patient segmentation, evidence generation, and lifecycle decisions.
  • Own the Friedreich ataxia competitive intelligence program, including key intelligence questions, monitoring competitor clinical, regulatory, and commercial activity, scenario planning and war gaming, and regular updates to leadership and cross-functional partners.
  • Lead global brand development for LX2006, including brand naming and trademark activities, brand identity, and the brand book.
  • Develop and deploy unbranded disease-awareness and branded healthcare professional and patient campaigns across channels; manage creative and media agencies and the medical/legal/regulatory review process.
  • Build and refine the prescriber, account, and treatment center universe across neurology and cardiology using claims and other third-party data; define targeting and segmentation; and partner with Medical and Market Access on treatment center mapping, readiness assessments, and referral pathways.
  • Develop and execute the commercial healthcare professional and key opinion leader engagement plan, including a key opinion leader steering committee, peer-to-peer programs, advisory boards, and medical congress presence, in compliant partnership with Medical Affairs.
  • Support ex-U.S. launch sequencing and go-to-market planning, ensuring global brand strategy, insights, and materials can be adapted for priority markets as LX2006 expands beyond the U.S.
  • Develop core launch materials, including sales aids, leave-behinds, websites, and congress assets, and contribute to field training, launch meeting, and plan-of-action planning ahead of field deployment.
  • Support early commercial planning for LX2020 in PKP2-associated arrhythmogenic cardiomyopathy, including target product profile development, healthcare professional and payer research, patient segmentation, market sizing, and commercial input to pivotal trial design, leveraging synergies with LX2006.
  • Manage marketing budgets, statements of work, and vendor relationships across market research, data, creative, and strategy partners; track spend against plan and contribute to annual budget planning.
  • Help scale the team as launch approaches and contribute to a collaborative, cross-functional commercial mindset and culture.

Desired Qualifications

  • Gene therapy or cell and gene therapy launch experience.
  • Prior management or strategy consulting experience in life sciences.
  • Experience in cardiology and/or neurology marketing.
  • Exposure to market access, pricing, and reimbursement for high-cost, one-time therapies.
  • Global or ex-U.S. launch experience, including familiarity with health technology assessment requirements.

About the Company

Lexeo Therapeutics

Gene therapy for cardiac, neurological diseases

Lexeo Therapeutics develops gene therapies for genetic cardiac and neurological diseases. It advances therapies by conducting research, running clinical trials, and pursuing commercialization through partnerships and grants. It differentiates itself with a strong academic foundation and collaboration with Weill Cornell’s Department of Genetic Medicine, while focusing on end-to-end development from discovery to trials. Its goal is to bring genetic medicines to patients with unmet medical needs through partnerships, clinical trials, and eventual market availability.

Company size
51-200
Company stage
IPO
Headquarters
New York City, New York
Founded
2018

Recently Posted Jobs

Explore more opportunities at Lexeo Therapeutics

See more jobs